Latest Close
$3.92
News
ADIL
Adial Pharmaceuticals, Inc News
This news view pulls recent coverage and headlines tied to ADIL.
1y Change
-$5.08 (-56.44%)
Market Cap
$10,293,489.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
GlobeNewswire • Oct 16, 2026
Read articleAdial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Sep 30, 2026
Read articleAdial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Aug 25, 2026
Read articleAdial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
GlobeNewswire • Aug 17, 2026
Read article